Search all medical codes

Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter

ICD10CM code

Name of the Condition

  • Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
  • Other terms: Drug-induced lipid disorders, Statin side effects

Summary

This condition refers to negative reactions experienced when starting treatment with medications designed to lower lipid levels in the blood or prevent arteriosclerosis. These medications are often prescribed to manage cholesterol levels and prevent cardiovascular disease.

Causes

The condition is caused by the body's adverse reactions to drugs that are used to treat high cholesterol and prevent arterial disease. Some drugs involved include statins, fibrates, niacin, and PCSK9 inhibitors.

Risk Factors

  • First-time use of antihyperlipidemic or antiarteriosclerotic drugs.
  • Pre-existing liver or kidney issues.
  • Concurrent use of other medications that interact with the primary drug.
  • Personal or family history of drug allergies.

Symptoms

  • Muscle pain or weakness (myopathy).
  • Liver enzyme abnormalities.
  • Digestive problems such as nausea or diarrhea.
  • Allergic reactions, including rashes or itching.
  • Neurological symptoms like memory loss or confusion.

Diagnosis

  • Patient history and review of recent drug administration.
  • Blood tests, including liver function tests and creatine kinase levels.
  • Physical examination focused on muscle strength and pain assessment.

Treatment Options

  • Discontinuation or adjustment of the offending medication.
  • Switching to a different class of lipid-lowering drug.
  • Supportive therapies to manage symptoms, like pain relief medications.

Prognosis and Follow-Up

  • Many patients recover fully after discontinuing the medication or changing to an alternative.
  • Regular follow-ups are important to monitor liver function and muscle integrity if medication is adjusted.

Complications

  • Rhabdomyolysis, a severe breakdown of muscle tissue.
  • Liver damage if liver enzyme levels remain elevated.
  • Increased risk of cardiovascular events if lipid control is not managed.

Lifestyle & Prevention

  • Regular blood checks to monitor lipid levels and organ function when commencing any new lipid-lowering medication.
  • Maintaining a healthy diet and active lifestyle to support drug therapy.

When to Seek Professional Help

  • Onset of severe muscle pain, weakness, or dark-colored urine.
  • Signs of liver issues such as yellowing of the skin or eyes.
  • Persistent or severe gastrointestinal symptoms.

Additional Resources

Tips for Medical Coders

  • Ensure documentation specifies that this is an initial encounter for the adverse drug effect.
  • Verify the specific drug causing the adverse effect to accurately code related conditions.
  • Avoid confusion with conditions related to the intended disease treatment, such as arteriosclerosis itself.

Medical Policies and Guidelines for Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter

Related policies from health plans

Similar Codes